Aigen Investment Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-16,839
Closed -$738K – 608
2025
Q4
$738K Buy
+16,839
New +$697K 0.17% 174
2025
Q3
– Sell
-4,699
Closed -$207K – 882
2025
Q2
$207K Buy
+4,699
New +$188K 0.03% 655
2024
Q1
– Sell
-20,251
Closed -$486K – 772
2023
Q4
$486K Buy
+20,251
New +$440K 0.09% 338
2023
Q2
– Sell
-24,137
Closed -$468K – 817
2023
Q1
$468K Buy
+24,137
New +$421K 0.06% 326
2022
Q4
– Sell
-16,558
Closed -$260K – 610
2022
Q3
$260K Buy
+16,558
New +$320K 0.04% 440
2020
Q4
– Sell
-11,637
Closed -$285K – 851
2020
Q3
$285K Buy
+11,637
New +$272K 0.04% 556

Other funds holding EXEL

Aigen Investment Management's EXEL Position: Q1 2026 in Review

Aigen Investment Management sold out of Exelixis (EXEL) in Q1 2026, closing a stake of 16,839 shares — an estimated $738K sold.

Aigen Investment Management first reported a position in EXEL in Q3 2020 and held it in 6 quarters. The position peaked at $738K in Q4 2025. 701 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Aigen Investment Management reported no remaining Exelixis position as of Q1 2026 after selling out during the quarter.
  • Aigen Investment Management sold 16,839 Exelixis shares in Q1 2026, an estimated $738K.
  • Aigen Investment Management first reported a position in Exelixis in Q3 2020 and held it in 6 quarters.
  • Aigen Investment Management's Exelixis position peaked at $738K in Q4 2025.
  • 701 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.